Amid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts and Skyrizi delivers
Amid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts [...]
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and China units lag
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and [...]
As superstar Revlimid fades faster than expected, BMS trims $600M from its 2022 sales projection
As superstar Revlimid fades faster than expected, BMS trims $600M [...]
Fierce Pharma Asia—Astellas’ gene therapy ding; BeiGene, Novartis’ PD-1 win; Serum Institute’s unused COVID shots
Fierce Pharma Asia—Astellas’ gene therapy ding; BeiGene, Novartis’ PD-1 win; [...]
If Lilly’s Alzheimer’s prospect proves its merit, it’s ‘inconceivable’ CMS wouldn’t cover the med: exec
If Lilly’s Alzheimer’s prospect proves its merit, it’s ‘inconceivable’ CMS [...]
Amgen vows to fight $7.1B tax bill tied to Puerto Rico manufacturing unit
Amgen vows to fight $7.1B tax bill tied to Puerto [...]
Novartis confirms ‘thousands’ of layoffs loom as its global reorganization rolls ahead
Novartis confirms ‘thousands’ of layoffs loom as its global reorganization [...]
FDA expands approval of Gilead’s Veklury, providing young children their first COVID treatment option
FDA expands approval of Gilead’s Veklury, providing young children their [...]
FDA plans study into how patients and physicians make prescription decisions
FDA plans study into how patients and physicians make prescription [...]
Roche delays Polivy’s blockbuster lymphoma filing as FDA asks for more data
Roche delays Polivy’s blockbuster lymphoma filing as FDA asks for [...]